Bacterial DNA amplifies neutrophilic inflammation in IL-17-exposed airways

Background Neutrophilic asthma (NA) is associated with increased airway interleukin (IL)-17 and abnormal bacterial community such as dominance of nontypeable Haemophilus influenzae (NTHi), particularly during asthma exacerbations. Bacteria release various products including DNA, but whether they coo...

Full description

Bibliographic Details
Main Authors: Nastaran Mues, Richard J. Martin, Rafeul Alam, Niccolette Schaunaman, Kris Genelyn Dimasuay, Christena Kolakowski, Clyde J. Wright, Lijun Zheng, Hong Wei Chu
Format: Article
Language:English
Published: European Respiratory Society 2023-01-01
Series:ERJ Open Research
Online Access:http://openres.ersjournals.com/content/9/1/00474-2022.full
_version_ 1797809426038521856
author Nastaran Mues
Richard J. Martin
Rafeul Alam
Niccolette Schaunaman
Kris Genelyn Dimasuay
Christena Kolakowski
Clyde J. Wright
Lijun Zheng
Hong Wei Chu
author_facet Nastaran Mues
Richard J. Martin
Rafeul Alam
Niccolette Schaunaman
Kris Genelyn Dimasuay
Christena Kolakowski
Clyde J. Wright
Lijun Zheng
Hong Wei Chu
author_sort Nastaran Mues
collection DOAJ
description Background Neutrophilic asthma (NA) is associated with increased airway interleukin (IL)-17 and abnormal bacterial community such as dominance of nontypeable Haemophilus influenzae (NTHi), particularly during asthma exacerbations. Bacteria release various products including DNA, but whether they cooperate with IL-17 in exaggerating neutrophilic inflammation is unclear. We sought to investigate the role of bacteria-derived DNA in airway neutrophilic inflammation related to IL-17-high asthma and underlying mechanisms (e.g. Toll-like receptor 9 (TLR9)/IL-36γ signalling axis). Methods Bacterial DNA, IL-8 and IL-36γ were measured in bronchoalveolar lavage fluid (BALF) of people with asthma and healthy subjects. The role of co-exposure to IL-17 and bacterial DNA or live bacteria in neutrophilic inflammation, and the contribution of the TLR9/IL-36γ signalling axis, were determined in cultured primary human airway epithelial cells and alveolar macrophages, and mouse models. Results Bacterial DNA levels were increased in asthma BALF, which positively correlated with IL-8 and neutrophil levels. Moreover, IL-36γ increased in BALF of NA patients. Bacterial DNA or NTHi infection under an IL-17-high setting amplified IL-8 production and mouse lung neutrophilic inflammation. DNase I treatment in IL-17-exposed and NTHi-infected mouse lungs reduced neutrophilic inflammation. Mechanistically, bacterial DNA-mediated amplification of neutrophilic inflammation is in part dependent on the TLR9/IL-36γ signalling axis. Conclusions Bacterial DNA amplifies airway neutrophilic inflammation in an IL-17-high setting partly through the TLR9 and IL-36γ signalling axis. Our novel findings may offer several potential therapeutic targets including TLR9 antagonists, IL-36γ neutralising antibodies and DNase I to reduce asthma severity associated with exaggerated airway neutrophilic inflammation.
first_indexed 2024-03-13T06:52:33Z
format Article
id doaj.art-474caab9c4564a6d811312a57cb6b93c
institution Directory Open Access Journal
issn 2312-0541
language English
last_indexed 2024-03-13T06:52:33Z
publishDate 2023-01-01
publisher European Respiratory Society
record_format Article
series ERJ Open Research
spelling doaj.art-474caab9c4564a6d811312a57cb6b93c2023-06-07T13:30:44ZengEuropean Respiratory SocietyERJ Open Research2312-05412023-01-019110.1183/23120541.00474-202200474-2022Bacterial DNA amplifies neutrophilic inflammation in IL-17-exposed airwaysNastaran Mues0Richard J. Martin1Rafeul Alam2Niccolette Schaunaman3Kris Genelyn Dimasuay4Christena Kolakowski5Clyde J. Wright6Lijun Zheng7Hong Wei Chu8 Department of Medicine, National Jewish Health, Denver, CO, USA Department of Medicine, National Jewish Health, Denver, CO, USA Department of Medicine, National Jewish Health, Denver, CO, USA Department of Medicine, National Jewish Health, Denver, CO, USA Department of Medicine, National Jewish Health, Denver, CO, USA Department of Medicine, National Jewish Health, Denver, CO, USA Department of Pediatrics, Children's Hospital of Colorado, University of Colorado School of Medicine, Aurora, CO, USA Department of Pediatrics, Children's Hospital of Colorado, University of Colorado School of Medicine, Aurora, CO, USA Department of Medicine, National Jewish Health, Denver, CO, USA Background Neutrophilic asthma (NA) is associated with increased airway interleukin (IL)-17 and abnormal bacterial community such as dominance of nontypeable Haemophilus influenzae (NTHi), particularly during asthma exacerbations. Bacteria release various products including DNA, but whether they cooperate with IL-17 in exaggerating neutrophilic inflammation is unclear. We sought to investigate the role of bacteria-derived DNA in airway neutrophilic inflammation related to IL-17-high asthma and underlying mechanisms (e.g. Toll-like receptor 9 (TLR9)/IL-36γ signalling axis). Methods Bacterial DNA, IL-8 and IL-36γ were measured in bronchoalveolar lavage fluid (BALF) of people with asthma and healthy subjects. The role of co-exposure to IL-17 and bacterial DNA or live bacteria in neutrophilic inflammation, and the contribution of the TLR9/IL-36γ signalling axis, were determined in cultured primary human airway epithelial cells and alveolar macrophages, and mouse models. Results Bacterial DNA levels were increased in asthma BALF, which positively correlated with IL-8 and neutrophil levels. Moreover, IL-36γ increased in BALF of NA patients. Bacterial DNA or NTHi infection under an IL-17-high setting amplified IL-8 production and mouse lung neutrophilic inflammation. DNase I treatment in IL-17-exposed and NTHi-infected mouse lungs reduced neutrophilic inflammation. Mechanistically, bacterial DNA-mediated amplification of neutrophilic inflammation is in part dependent on the TLR9/IL-36γ signalling axis. Conclusions Bacterial DNA amplifies airway neutrophilic inflammation in an IL-17-high setting partly through the TLR9 and IL-36γ signalling axis. Our novel findings may offer several potential therapeutic targets including TLR9 antagonists, IL-36γ neutralising antibodies and DNase I to reduce asthma severity associated with exaggerated airway neutrophilic inflammation.http://openres.ersjournals.com/content/9/1/00474-2022.full
spellingShingle Nastaran Mues
Richard J. Martin
Rafeul Alam
Niccolette Schaunaman
Kris Genelyn Dimasuay
Christena Kolakowski
Clyde J. Wright
Lijun Zheng
Hong Wei Chu
Bacterial DNA amplifies neutrophilic inflammation in IL-17-exposed airways
ERJ Open Research
title Bacterial DNA amplifies neutrophilic inflammation in IL-17-exposed airways
title_full Bacterial DNA amplifies neutrophilic inflammation in IL-17-exposed airways
title_fullStr Bacterial DNA amplifies neutrophilic inflammation in IL-17-exposed airways
title_full_unstemmed Bacterial DNA amplifies neutrophilic inflammation in IL-17-exposed airways
title_short Bacterial DNA amplifies neutrophilic inflammation in IL-17-exposed airways
title_sort bacterial dna amplifies neutrophilic inflammation in il 17 exposed airways
url http://openres.ersjournals.com/content/9/1/00474-2022.full
work_keys_str_mv AT nastaranmues bacterialdnaamplifiesneutrophilicinflammationinil17exposedairways
AT richardjmartin bacterialdnaamplifiesneutrophilicinflammationinil17exposedairways
AT rafeulalam bacterialdnaamplifiesneutrophilicinflammationinil17exposedairways
AT niccoletteschaunaman bacterialdnaamplifiesneutrophilicinflammationinil17exposedairways
AT krisgenelyndimasuay bacterialdnaamplifiesneutrophilicinflammationinil17exposedairways
AT christenakolakowski bacterialdnaamplifiesneutrophilicinflammationinil17exposedairways
AT clydejwright bacterialdnaamplifiesneutrophilicinflammationinil17exposedairways
AT lijunzheng bacterialdnaamplifiesneutrophilicinflammationinil17exposedairways
AT hongweichu bacterialdnaamplifiesneutrophilicinflammationinil17exposedairways